V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20059090 | 20133773 | 1.87 | 55.3 | 03 | 2019-02-06 | 2020-01-05 | DARATUMUMAB | null | N | CAPECITABINE + LOMUSTINE | 101331262 |
| 20059093 | 20133774 | 1.72 | 149 | Curative (C) | 2016-04-24 | 2016-04-25 | FCarboSt | 02 | N | METHOTREXATE | 101346461 |
| 20059136 | 20133775 | 1.6 | 87 | Palliative (P) | 2016-09-29 | 2016-10-11 | Chlorambucil | 02 | N | IBRUTINIB | 101550392 |
| 20059142 | 20133776 | 1.75 | null | null | 2018-08-29 | 2018-09-05 | ECF | 02 | Y | CAPECITABINE + OXALIPLATIN + TRASTUZUMAB | 100429515 |
| 20059198 | 20133777 | 1.8 | 85 | 03 | null | 2019-09-25 | Olaratumab | null | N | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + PERTUZUMAB + TRASTUZUMAB | 100561399 |
| 20059260 | 20133778 | 1.9 | 91.3 | null | null | 2018-03-08 | Melpahan IV Low dose | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101748412 |
| 20059271 | 20133779 | 1.79 | 69 | Palliative (P) | 2016-07-26 | 2016-08-23 | ECF | 02 | null | GEMCITABINE + OXALIPLATIN | 100261787 |
| 20059322 | 20133780 | 1.57 | 64.8 | Curative (C) | 2016-04-05 | 2018-08-06 | OXALIPLATIN + MDG + PANITUMUMAB | 01 | N | NIRAPARIB | 101565273 |
| 20059335 | 20133781 | 1.76 | 104 | null | 2019-08-27 | 2019-09-02 | EOF | 02 | null | POMALIDOMIDE | 101574350 |
| 20059528 | 20133782 | null | 50 | Palliative (P) | 2020-01-28 | 2020-01-28 | Cisplatin +FU +Trastuzumab - Maint | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101734111 |
| 20059552 | 20133783 | 1.65 | 115.4 | Curative (C) | 2021-07-25 | 2021-08-13 | Rituximab | 02 | N | IRINOTECAN + MDG + PANITUMUMAB | 101537328 |
| 20059590 | 20133784 | 1.81 | null | Palliative (P) | 2017-03-16 | 2017-04-02 | Pazopanib | N | null | RADIUM 223 | 101456514 |
| 20059646 | 20133785 | 1.65 | 67 | null | 2017-07-13 | 2017-07-13 | null | 02 | N | IPILIMUMAB + NIVOLUMAB | 100357786 |
| 20059654 | 20133786 | 1.77 | 92 | Palliative (P) | 2019-09-27 | 2019-09-27 | MITOMYCIN | Y | N | CAPECITABINE + CETUXIMAB + OXALIPLATIN | 100158954 |
| 20059704 | 20133789 | 1.51 | 16.1 | null | 2019-07-26 | 2019-08-03 | Bevacizumab + Oxaliplatin +MdG | 02 | null | CYTARABINE HIGH DOSE | 101383789 |
| 20059746 | 20133790 | null | 94 | Adjuvant (A) | 2019-12-20 | 2019-12-25 | Capecitabine + Streptozocin | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 100684426 |
| 20059818 | 20133792 | null | 44.1 | Palliative (P) | 2019-06-28 | 2021-01-05 | AFATINIB | 2 | N | FCARBOST | 101771170 |
| 20059978 | 20133794 | 1.69 | 64 | Palliative (P) | 2019-12-08 | 2019-12-16 | IPILIMUMAB + NIVOLUMAB | 02 | N | CETUXIMAB + RT | 100126921 |
| 20060043 | 20133795 | 1.81 | 101.4 | Disease modification (D) | 2019-01-28 | 2019-02-13 | Palbociclib | 02 | null | GEFITINIB | 101354502 |
| 20060087 | 20133796 | 1.57 | 52 | null | 2019-04-23 | 2019-11-03 | Pemetrexed | 02 | N | TOPOTECAN | 100135101 |
| 20060155 | 20133797 | 1.77 | 66 | Palliative (P) | 2017-03-02 | 2017-03-09 | Cetuximab + Irinotecan (Cycle 1) | 02 | null | ERIBULIN | 101403267 |
| 20060232 | 20133798 | 1.65 | 62.2 | 03 | 2018-09-18 | 2018-10-10 | null | N | null | IPILIMUMAB + NIVOLUMAB | 100376893 |
| 20060295 | 20133799 | 1.57 | null | null | 2017-11-29 | 2017-12-22 | ECF | 02 | null | LETROZOLE + PALBOCICLIB | 100322547 |
| 20060367 | 20133800 | 1.5 | 64.7 | Adjuvant (A) | 2019-01-18 | 2019-01-19 | Gemcitabine + Paclitaxel | null | Y | GEMCITABINE + RT | 100168449 |
| 20060391 | 20133801 | 1.69 | 47.2 | null | 2020-01-10 | 2020-01-11 | Capecitabine + Docetaxel | N | null | PLATO TRIAL | 101710700 |
| 20060394 | 20133802 | 1.9 | 117 | Adjuvant (A) | 2018-08-27 | 2018-08-27 | Hepatoblastoma Relapse VI | 01 | N | CAPECITABINE + STREPTOZOCIN | 101416467 |
| 20060449 | 20133803 | 1.65 | 59.6 | Adjuvant (A) | 2017-08-12 | 2017-08-31 | Gemcitabine+Paclitaxel (Neo-tAnGo) | 02 | null | COSMIC TRIAL | 100132558 |
| 20060457 | 20133804 | 1.57 | 117.5 | Palliative (P) | 2019-05-07 | 2019-05-07 | Capecitabine + Docetaxel | 02 | N | EPIRUBICIN | 101549686 |
| 20060677 | 20133805 | 0 | 81 | null | 2019-11-11 | 2019-11-12 | TEMOZOLOMIDE | 02 | N | GEMCITABINE + OXALIPLATIN | 101834878 |
| 20060783 | 20133806 | 1.56 | 56.5 | null | 2020-02-27 | 2020-03-05 | Cisplatin + Pemetrexed | 02 | null | CABOZANTINIB | 100120443 |
| 20060818 | 20133807 | 1.8 | null | Curative (C) | 2018-07-08 | 2019-11-13 | Carboplatin + Fluorouracil + Streptozocin | 02 | null | CABAZITAXEL | 101304588 |
| 20060868 | 20133808 | 1.42 | 90.2 | Palliative (P) | 2020-08-24 | 2020-09-06 | CAP + RT | 02 | null | LETROZOLE + PALBOCICLIB | 101005077 |
| 20061049 | 20133809 | null | null | Palliative (P) | 2015-09-06 | 2016-04-20 | Ixazomib + Lenalidomide | 01 | N | CAPECITABINE + STREPTOZOCIN | 101611059 |
| 20061064 | 20133810 | 1.82 | 53 | null | 2016-10-04 | 2016-10-25 | DOCETAXEL + GEMCITABINE | 02 | N | IRINOTECAN + MDG + PANITUMUMAB | 100872030 |
| 20061281 | 20133811 | 1.81 | 0 | null | 2018-02-20 | 2018-03-19 | ECarboX | 02 | null | CABOZANTINIB | 100906161 |
| 20061399 | 20133812 | 1.55 | 60.5 | Curative (C) | 2020-01-28 | 2020-02-05 | Letrozole + Palbociclib | 02 | N | CAPECITABINE + MITOMYCIN + RT | 101698301 |
| 20061525 | 20133815 | 1.81 | 101.5 | Palliative (P) | 2018-03-30 | 2018-04-07 | CEMIPLIMAB | 02 | N | CISPLATIN + TEYSUNO | 100048613 |
| 20061530 | 20133816 | 1.6 | 63.7 | Palliative (P) | 2022-01-01 | 2022-01-14 | CYCLO + DOXORUBICIN + VINCRISTINE | 02 | null | OXALIPLATIN + MDG + PANITUMUMAB | 101449398 |
| 20061586 | 20133817 | 1.75 | 110 | Curative (C) | 2021-05-24 | 2021-05-24 | Doxorubicin 75mg/m2 | 2 | N | HYDROXYCARBAMIDE | 100596696 |
| 20061606 | 20133818 | 1.72 | 83 | Curative (C) | 2018-09-24 | 2018-10-08 | CABOZANTINIB | 02 | null | COSMIC TRIAL | 101371613 |
| 20061625 | 20133819 | 1.69 | 75.5 | null | 2020-01-13 | 2020-01-23 | IBRUTINIB | 02 | null | FLUOROURACIL + RT | 100769388 |
| 20061667 | 20133820 | 1.69 | 100 | null | 2018-01-06 | 2018-10-16 | Capecitabine + Streptozocin | 02 | null | FLUOROURACIL + STREPTOZOCIN | 100850324 |
| 20062103 | 20133821 | 1.55 | 81.2 | null | 2018-11-20 | 2018-11-27 | CAV | 02 | null | GEMCITABINE + RT | 101829191 |
| 20062129 | 20133822 | 1.79 | 77 | 03 | 2021-06-02 | 2021-07-21 | Temozolomide + RT | 02 | N | IRINOTECAN + MDG + PANITUMUMAB | 100436061 |
| 20062389 | 20133824 | 1.23 | 77.7 | null | 2020-01-12 | 2020-01-25 | Pemetrexed | 02 | null | ETOPOSIDE | 100414109 |
| 20062544 | 20133825 | 1.65 | 28.6 | null | 2018-01-18 | 2018-02-10 | Hydroxycarbamide | null | null | PAZOPANIB | 101467938 |
| 20062545 | 20133826 | 1.69 | 91.5 | null | 2019-07-12 | 2019-07-14 | CISPLATIN + FLUOROURACIL + RT | 02 | N | CAPECITABINE + CISPLATIN + STREPTOZOCIN | 101244466 |
| 20062548 | 20133827 | 1.81 | 59 | null | 2017-12-18 | 2018-06-11 | DA 3+8 | N | null | BORTEZOMIB + DARATUMUMAB | 101677321 |
| 20062575 | 20133828 | 1.51 | 58.2 | Curative (C) | 2019-01-23 | 2019-02-26 | Bortezomib + Daratumumab | 01 | N | BUSULFAN | 101348017 |
| 20062614 | 20133829 | 1.79 | 87.1 | Palliative (P) | 2021-07-27 | 2022-04-09 | ECF | 02 | null | OXALIPLATIN + MDG + PANITUMUMAB | 101647803 |